Comparative Oral Bioavailability Study of MT-1303

Clinical trial NCT02310048 · COMPLETED

Trial details

NCT number: NCT02310048
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsing-remitting Multiple Sclerosis

Start date: 2014-11-01
Primary completion: 2015-03-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.